Last reviewed · How we verify

NCT07453303: HIV-AGE40

Comprehensive Geriatric Assessment in Adults Aged 40 Years and Older Living With HIV

Not yet recruiting Last updated 5 March 2026
What this trial tests

trial in Frailty in 80 participants. Not yet recruiting.

Timeline
2 March 2026
Primary endpoint
20 April 2026
20 April 2026

Quick facts

Lead sponsorSehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment80
Start date2 March 2026
Primary completion20 April 2026
Estimated completion20 April 2026

Conditions studied

Sponsor

Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital

Who can join

Adults 40 to 99, any sex, with Frailty or Sarcopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

People living with HIV are experiencing longer life expectancy due to effective antiretroviral therapy; however, they may develop age-related conditions earlier than the general population. This prospective observational study aims to evaluate frailty, sarcopenia, nutritional status, cognitive function, and functional performance in adults aged 40 years and older living with HIV and to compare them with age- and sex-matched healthy controls.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Frailty

Currently open trials in the same condition.

Other Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07453303.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing